{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:32:32Z","timestamp":1793338352103,"version":"4.5.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM038765"],"award-info":[{"award-number":["R01GM038765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01GM095467"],"award-info":[{"award-number":["P01GM095467"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.smim.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T17:32:14Z","timestamp":1428427934000},"page":"200-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":556,"title":["The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution"],"prefix":"10.1016","volume":"27","author":[{"given":"Charles N.","family":"Serhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesmond","family":"Dalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2015.03.004_bib1000","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1096\/fj.11-0502ufm","article-title":"The resolution of inflammation: the devil in the flask and in the details","volume":"25","author":"Serhan","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1005","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1074\/jbc.X112.351437","article-title":"Role of basic science in the development of new medicines: examples from the eicosanoid field","volume":"287","author":"Samuelsson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2015.03.004_bib1010","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1015","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1020","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1073\/pnas.0802572105","article-title":"Tonic inhibition of chemotaxis in human plasma","volume":"105","author":"Malawista","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12175","article-title":"Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo","volume":"498","author":"Lammermann","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.smim.2015.03.004_bib1030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri3362","article-title":"The resolution of inflammation","volume":"13","author":"Buckley","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1035","series-title":"Pathologic Basis of Disease","author":"Robbins","year":"1979"},{"key":"10.1016\/j.smim.2015.03.004_bib1040","series-title":"Metchnikoff and the Origins of Immunology: From Metaphor to Theory","author":"Tauber","year":"1991"},{"key":"10.1016\/j.smim.2015.03.004_bib1045","doi-asserted-by":"crossref","first-page":"8517","DOI":"10.1073\/pnas.1200189109","article-title":"Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling","volume":"109","author":"Norris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.smim.2015.03.004_bib1055","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1096\/fj.13-227728","article-title":"The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype","volume":"27","author":"Dalli","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamainternmed.2013.2299","article-title":"Why US adults use dietary supplements","volume":"173","author":"Bailey","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1065","article-title":"Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease","author":"Yates","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.smim.2015.03.004_bib1070","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1075","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation-resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.smim.2015.03.004_bib1080","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1096\/fj.12-225615","article-title":"D-series resolvins attenuate vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury","volume":"27","author":"Miyahara","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1085","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution","volume":"13","author":"Serhan","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.smim.2015.03.004_bib1090","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00011-012-0489-8","article-title":"Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis","volume":"61","author":"Chiu","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1095","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/srep01940","article-title":"Novel n\u22123 immunoresolvents: structures and actions","volume":"3","author":"Dalli","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2015.03.004_bib1100","doi-asserted-by":"crossref","first-page":"e102362","DOI":"10.1371\/journal.pone.0102362","article-title":"Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages","volume":"9","author":"Deng","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.164.2.1029","article-title":"Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia","volume":"164","author":"Bandeira-Melo","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI1578","article-title":"Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues","volume":"101","author":"Takano","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2015.03.004_bib1120","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4049\/jimmunol.0903816","article-title":"Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production","volume":"184","author":"Chan","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1125","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1152\/ajpregu.00128.2013","article-title":"Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment","volume":"305","author":"Markworth","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.smim.2015.03.004_bib1130","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.smim.2015.03.004_bib1135","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans","volume":"183","author":"Morris","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/mi.2013.102","article-title":"Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung","volume":"7","author":"Lucas","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1145","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-physiol-021113-170408","article-title":"Resolution of acute inflammation in the lung","volume":"76","author":"Levy","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.smim.2015.03.004_bib1150","doi-asserted-by":"crossref","first-page":"e1879","DOI":"10.1371\/journal.pone.0001879","article-title":"Anesthetics impact the resolution of inflammation","volume":"3","author":"Chiang","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1155","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.smim.2015.03.004_bib1160","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.smim.2015.03.004_bib1165","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.106.629907","article-title":"Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat","volume":"114","author":"Birnbaum","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.smim.2015.03.004_bib1170","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell\u2013leukocyte interactions","volume":"92","author":"Cl\u00e0ria","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.smim.2015.03.004_bib1175","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1073\/pnas.1308253110","article-title":"Ligand-specific conformational change of the G-protein-coupled receptor ALX\/FPR2 determines proresolving functional responses","volume":"110","author":"Cooray","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1180","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel proresolving aspirin-triggered DHA pathway","volume":"18","author":"Serhan","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.smim.2015.03.004_bib1185","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers anti-inflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1190","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1073\/pnas.1000373107","article-title":"Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways","volume":"107","author":"Morris","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10753-011-9294-8","article-title":"Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients","volume":"35","author":"Pillai","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.smim.2015.03.004_bib1200","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.1003865","article-title":"Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing","volume":"186","author":"Norling","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1205","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.smim.2015.03.004_bib1210","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/smll.201100442","article-title":"More effective nanomedicines through particle design","volume":"7","author":"Wang","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.smim.2015.03.004_bib1215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0022034514557331","article-title":"Proresolving nanomedicines activate bone regeneration in periodontitis","volume":"94","author":"Van Dyke","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1220","doi-asserted-by":"crossref","first-page":"20560","DOI":"10.1073\/pnas.1210269109","article-title":"Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions","volume":"109","author":"Jones","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1225","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2010.08.095","article-title":"Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis","volume":"400","author":"Tang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.smim.2015.03.004_bib1230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1235","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1182\/blood-2011-04-345330","article-title":"Transcriptomic analyses of murine resolution-phase macrophages","volume":"118","author":"Stables","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.smim.2015.03.004_bib1240","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1084\/jem.20121887","article-title":"Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators","volume":"210","author":"Miki","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2012.07.048","article-title":"Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma","volume":"131","author":"Miyata","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1250","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1096\/fj.10-170027","article-title":"Eosinophils promote resolution of acute periotonitis by producing proresolving mediators in mice","volume":"25","author":"Yamada","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jb\/mvs151","article-title":"Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3","volume":"153","author":"Isobe","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.smim.2015.03.004_bib1260","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1265","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1074\/jbc.M109.044131","article-title":"Resolvin E1 receptor activation signals phosphorylation and phagocytosis","volume":"285","author":"Ohira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2015.03.004_bib1270","doi-asserted-by":"crossref","first-page":"14983","DOI":"10.1073\/pnas.1206641109","article-title":"Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation","volume":"109","author":"El Kebir","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1275","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","article-title":"Resolvin D1 receptor stereoselectivity and regulation of inflammation and pro-resolving microRNAs","volume":"180","author":"Krishnamoorthy","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2015.03.004_bib1280","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/ATVBAHA.112.249508","article-title":"Resolvin D1 limits polymorphonuclear leukocytes recruitment to inflammatory loci: receptor dependent actions","volume":"32","author":"Norling","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.smim.2015.03.004_bib1285","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/srep00639","article-title":"Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA","volume":"2","author":"Fredman","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2015.03.004_bib1290","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.immuni.2013.10.011","article-title":"Plasticity of leukocytic exudates in resolving acute inflammation is regulated by microRNA and proresolving mediators","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2015.03.004_bib1295","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/mi.2013.7","article-title":"Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion","volume":"6","author":"Li","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1300","article-title":"The ALX\/FPR2 receptor for RvD1 is expressed and functional in salivary glands","author":"Nelson","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.smim.2015.03.004_bib1305","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1096\/fj.11-198069","article-title":"Transcriptional regulation of the human FPR2\/ALX gene: evidence of a heritable genetic variant that impairs promoter activity","volume":"26","author":"Simiele","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1310","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.smim.2015.03.004_bib1315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.plipres.2013.11.001","article-title":"Cell signaling mechanisms of oro-gustatory detection of dietary fat: advances and challenges","volume":"53","author":"Gilbertson","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1320","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/mol.110.066324","article-title":"Structure\u2013activity relationships of GPR120 agonists based on a docking simulation","volume":"78","author":"Sun","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.smim.2015.03.004_bib1325","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.smim.2015.03.004_bib1330","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.4049\/jimmunol.171.12.6856","article-title":"Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators","volume":"171","author":"Serhan","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1335","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.4049\/jimmunol.179.10.7021","article-title":"Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo","volume":"179","author":"Hasturk","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1340","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2013.10.008","article-title":"Lipid mediators in immune dysfunction after severe inflammation","volume":"35","author":"Fullerton","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1345","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2015.03.004_bib1350","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/SHK.0b013e31822798c1","article-title":"Lipoxin A4 increases survival by decreasing systemic inflammation and bacterial load in sepsis","volume":"36","author":"Walker","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.smim.2015.03.004_bib1355","doi-asserted-by":"crossref","first-page":"G487","DOI":"10.1152\/ajpgi.00042.2011","article-title":"Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production","volume":"301","author":"Prescott","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.smim.2015.03.004_bib1360","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ni.1758","article-title":"Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair","volume":"10","author":"Divangahi","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1365","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","article-title":"Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections","volume":"148","author":"Tobin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.smim.2015.03.004_bib1370","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1167\/iovs.13-12152","article-title":"Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology","volume":"54","author":"Rajasagi","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.smim.2015.03.004_bib1375","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","article-title":"Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1","volume":"186","author":"Rajasagi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1380","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1128\/JVI.00553-10","article-title":"Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection","volume":"84","author":"Cilloniz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2015.03.004_bib1385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2013.02.027","article-title":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza","volume":"153","author":"Morita","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.smim.2015.03.004_bib1390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2013.05.052","article-title":"Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation","volume":"154","author":"Tam","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.smim.2015.03.004_bib1395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2353\/ajpath.2009.080671","article-title":"Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis","volume":"174","author":"Wu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2015.03.004_bib1400","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1371\/journal.pone.0001316","article-title":"Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1","volume":"2","author":"Haas-Stapleton","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1405","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2014-03-564609","article-title":"Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap\u2212\/\u2212 mice","volume":"124","author":"Hsieh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.smim.2015.03.004_bib1410","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJMcibr1304414","article-title":"Influenza \u2013 time to target the host","volume":"369","author":"Baillie","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1415","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1096\/fj.11-198036","article-title":"Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea","volume":"26","author":"Wang","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1420","series-title":"The Effect of Resolvins on Dermal Wound Healing","author":"Menon","year":"2012"},{"key":"10.1016\/j.smim.2015.03.004_bib1425","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/db12-0684","article-title":"Proresolution therapy for the treatment of delayed healing of diabetic wounds","volume":"62","author":"Tang","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.smim.2015.03.004_bib1430","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","article-title":"Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases","volume":"19","author":"Spite","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.smim.2015.03.004_bib1435","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2015.03.004_bib1440","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2015.03.004_bib1445","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prostaglandins.2005.04.004","article-title":"Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins \u2013 mediator lipidomic analysis","volume":"78","author":"Hong","year":"2005","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.smim.2015.03.004_bib1450","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2015.03.004_bib1455","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1194\/jlr.R001131","article-title":"Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1","volume":"51","author":"Bazan","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1460","first-page":"1747","article-title":"Microglial ramification and redistribution concomitant with the attenuation of choroidal neovascularization by neuroprotectin D1","volume":"19","author":"Sheets","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.smim.2015.03.004_bib1465","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2012.04.007","article-title":"Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke","volume":"236","author":"Bazan","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.smim.2015.03.004_bib1470","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/jnc.12439","article-title":"A lipid neurochemist's siren: docosahexaenoic acid and its elusive function in the central nervous system","volume":"127","author":"Murphy","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.smim.2015.03.004_bib1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2014.05.335","article-title":"Resolution of inflammation is altered in Alzheimer's disease","author":"Wang","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.smim.2015.03.004_bib1480","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-121735","article-title":"1alpha,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-beta phagocytosis and inflammation in Alzheimer's Disease patients","volume":"34","author":"Mizwicki","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.smim.2015.03.004_bib1485","first-page":"60","article-title":"Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1","volume":"1","author":"Liu","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.smim.2015.03.004_bib1490","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12031-010-9355-8","article-title":"Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia","volume":"42","author":"Wu","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.smim.2015.03.004_bib1495","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbrc.2011.04.013","article-title":"Lipoxin A4 inhibits the production of proinflammatory cytokines induced by beta-amyloid in vitro and in vivo","volume":"408","author":"Wu","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.smim.2015.03.004_bib1500","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12031-012-9807-4","article-title":"Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia\/reperfusion injury","volume":"48","author":"Wu","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.smim.2015.03.004_bib1505","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.01.079","article-title":"Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion","volume":"1323","author":"Ye","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1510","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1523\/JNEUROSCI.5529-08.2009","article-title":"Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke","volume":"29","author":"Sobrado","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2015.03.004_bib1515","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1179\/1743132813Y.0000000242","article-title":"Lipoxin A4 ameliorates cerebral ischaemia\/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2","volume":"35","author":"Wu","year":"2013","journal-title":"Neurol. Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1520","doi-asserted-by":"crossref","first-page":"21134","DOI":"10.1073\/pnas.1202906109","article-title":"Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor","volume":"109","author":"Pamplona","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1525","doi-asserted-by":"crossref","first-page":"e55859","DOI":"10.1371\/journal.pone.0055859","article-title":"Proresolution lipid mediators in multiple sclerosis \u2013 differential, disease severity-dependent synthesis \u2013 a clinical pilot trial","volume":"8","author":"Pruss","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1530","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20061826","article-title":"Lipoxins and aspirin-triggered lipoxin stop inflammatory pain processing","volume":"204","author":"Svensson","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1535","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.plipres.2013.11.002","article-title":"TRP-channels as key integrators of lipid pathways in nociceptive neurons","volume":"53","author":"Sisignano","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1540","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1545","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1476-5381.2010.00909.x","article-title":"Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception","volume":"161","author":"Bang","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.smim.2015.03.004_bib1550","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1476-5381.2011.01568.x","article-title":"17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception","volume":"165","author":"Bang","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.smim.2015.03.004_bib1555","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1523\/JNEUROSCI.2443-11.2011","article-title":"Resolving TRPV1 and TNF-\u03b1-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2015.03.004_bib1560","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.23928","article-title":"Neuroprotectin\/protectin D1 protects against neuropathic pain in mice after nerve trauma","volume":"74","author":"Xu","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.smim.2015.03.004_bib1565","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","article-title":"Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2015.03.004_bib1570","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.pain.2010.11.021","article-title":"Enduring prevention and transient reduction of post-operative pain by intrathecal resolvin D1","volume":"152","author":"Huang","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.smim.2015.03.004_bib1575","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1476-5381.2011.01345.x","article-title":"The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats","volume":"164","author":"Lima-Garcia","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.smim.2015.03.004_bib1580","doi-asserted-by":"crossref","first-page":"e75543","DOI":"10.1371\/journal.pone.0075543","article-title":"Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release","volume":"8","author":"Abdelmoaty","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1585","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1096\/fj.13-230276","article-title":"Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline","volume":"27","author":"Terrando","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1590","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.pain.2013.07.028","article-title":"Targeted alteration of dietary n\u22123 and n\u22126 fatty acids for the treatment of chronic headaches: a randomized trial","volume":"154","author":"Ramsden","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.smim.2015.03.004_bib1595","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20132103","article-title":"Vagus nerve controls resolution and pro-resolving mediators of inflammation","volume":"211","author":"Mirakaj","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1600","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","article-title":"Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice","volume":"86C","author":"Klein","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.smim.2015.03.004_bib1605","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1096\/fj.10-170340","article-title":"A role for lipoxin A4 as anti-inflammatory and proresolution mediator in human parturition","volume":"25","author":"Maldonado-P\u00e8riz","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1610","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.4049\/jimmunol.1202807","article-title":"Spontaneous miscarriages are explained by the stress\/glucocorticoid\/lipoxin A4 axis","volume":"190","author":"Xu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1615","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/REP-11-0021","article-title":"A role for lipoxin A4 as an anti-inflammatory mediator in the human endometrium","volume":"142","author":"Macdonald","year":"2011","journal-title":"Reproduction"},{"key":"10.1016\/j.smim.2015.03.004_bib1620","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1096\/fj.11-187658","article-title":"Lipoxin A4 is a novel estrogen receptor modulator","volume":"25","author":"Russell","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1625","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/REP-12-0469","article-title":"Lipoxin A(4) blocks embryo implantation by controlling estrogen receptor alpha activity","volume":"145","author":"Xiong","year":"2013","journal-title":"Reproduction"},{"key":"10.1016\/j.smim.2015.03.004_bib1630","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.biopha.2005.05.005","article-title":"Regulatory expression of lipoxin A4 receptor in physiologically estrus cycle and pathologically endometriosis","volume":"59","author":"Motohashi","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.smim.2015.03.004_bib1635","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/mi.2013.9","article-title":"The role of lipoxin A4 in endometrial biology and endometriosis","volume":"6","author":"Canny","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1640","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.plefa.2012.08.003","article-title":"Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma","volume":"87","author":"Gil-Villa","year":"2012","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.smim.2015.03.004_bib1645","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1194\/jlr.M039842","article-title":"Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta","volume":"54","author":"Jones","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1650","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/srep03113","article-title":"Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth","volume":"3","author":"Yamashita","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2015.03.004_bib1655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1476-511X-12-89","article-title":"High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation","volume":"12","author":"Weiss","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.smim.2015.03.004_bib1660","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncprheum0375","article-title":"Mechanisms of disease: leukotrienes and lipoxins in scleroderma lung disease \u2013 insights and potential therapeutic implications","volume":"3","author":"Kowal-Bielecka","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.smim.2015.03.004_bib1665","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.4049\/jimmunol.0802259","article-title":"ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis","volume":"182","author":"Martins","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1670","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1096\/fj.11-185017","article-title":"Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis","volume":"25","author":"Borgeson","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1675","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/path.4050","article-title":"Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation","volume":"228","author":"Qu","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.smim.2015.03.004_bib1680","doi-asserted-by":"crossref","first-page":"e58258","DOI":"10.1371\/journal.pone.0058258","article-title":"A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation","volume":"8","author":"Hsiao","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1685","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10555-011-9311-2","article-title":"Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer","volume":"30","author":"Janakiram","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.smim.2015.03.004_bib1690","series-title":"Role of Resolvin D1 in Experimentally Induced Inflammation and Colon Carcinogenesis","author":"Lee","year":"2013"},{"key":"10.1016\/j.smim.2015.03.004_bib1695","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-013-0363-y","article-title":"Resolution of inflammation as a novel chemopreventive strategy","volume":"35","author":"Lee","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.smim.2015.03.004_bib1700","series-title":"13th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases","article-title":"Stimulation of inflammation resolution by resolvins inhibits tumor growth (abstract)","author":"Panigrahy","year":"2013"},{"key":"10.1016\/j.smim.2015.03.004_bib1705","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.1103483","article-title":"Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells","volume":"189","author":"Ramon","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1710","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jasms.2006.09.002","article-title":"Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: analysis via electrospray\/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms","volume":"18","author":"Hong","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.smim.2015.03.004_bib1715","doi-asserted-by":"crossref","first-page":"43079","DOI":"10.1074\/jbc.M509796200","article-title":"The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering","volume":"280","author":"Ariel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2015.03.004_bib1720","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ni1392","article-title":"Apoptotic neutrophils and T cells sequester chemokines during immune response resolution via modulation of CCR5 expression","volume":"7","author":"Ariel","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1725","doi-asserted-by":"crossref","first-page":"318621","DOI":"10.1155\/2012\/318621","article-title":"Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis","volume":"2012","author":"Settimio","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.smim.2015.03.004_bib1730","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1167\/iovs.08-3146","article-title":"Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions","volume":"50","author":"Tian","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.smim.2015.03.004_bib1735","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.4049\/jimmunol.181.7.4534","article-title":"Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells","volume":"181","author":"Vassiliou","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1740","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.intimp.2012.08.005","article-title":"Omega-3 fatty acid-derived mediator, resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC\/Nga mice","volume":"14","author":"Kim","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.smim.2015.03.004_bib1745","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1750","doi-asserted-by":"crossref","first-page":"e76575","DOI":"10.1371\/journal.pone.0076575","article-title":"Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids","volume":"8","author":"Nording","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1755","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.4049\/jimmunol.1300699","article-title":"Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways","volume":"191","author":"Divanovic","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1760","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1182\/blood-2010-11-317750","article-title":"Delta12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice","volume":"118","author":"Hegde","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.smim.2015.03.004_bib1765","series-title":"13th International Conference on Bioactive Lipids in Cancer, Inflammation, and Related Diseases","article-title":"Clinical generation and dietary modulation of anti-inflammatory electrophilic omega-3 fatty acid derivatives (abstract #178)","author":"Cipollina","year":"2013"},{"key":"10.1016\/j.smim.2015.03.004_bib1770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(97)00001-5","article-title":"The isoprostanes: unique bioactive products of lipid peroxidation","volume":"36","author":"Morrow","year":"1997","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1775","doi-asserted-by":"crossref","first-page":"137ra73","DOI":"10.1126\/scitranslmed.3003831","article-title":"Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation","volume":"4","author":"Ho","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1780","doi-asserted-by":"crossref","first-page":"e16957","DOI":"10.1371\/journal.pone.0016957","article-title":"The human serum metabolome","volume":"6","author":"Psychogios","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1785","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2012.190199","article-title":"D2, and other mediators of self-limited resolution of inflammation in human blood following n\u22123 fatty acid supplementation","volume":"58","author":"Mas","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.smim.2015.03.004_bib1790","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.4049\/jimmunol.169.12.7063","article-title":"An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile","volume":"169","author":"Schottelius","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1795","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2133.2012.11177.x","article-title":"Efficacy and Safety of 15(R\/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema","volume":"168","author":"Wu","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.smim.2015.03.004_bib1800","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/ajrccm\/145.6.1281","article-title":"The effects of lipoxin A4 on airway responses in asthmatic subjects","volume":"145","author":"Christie","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.smim.2015.03.004_bib1805","doi-asserted-by":"crossref","first-page":"E4753","DOI":"10.1073\/pnas.1415006111","article-title":"Identification of sulfido-conjugated mediators that promote resolution of infection and organ protection","volume":"111","author":"Dalli","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1810","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1465-9921-11-71","article-title":"Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma","volume":"11","author":"Bhavsar","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.smim.2015.03.004_bib1815","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1365-2222.2011.03839.x","article-title":"Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma","volume":"41","author":"Yamaguchi","year":"2011","journal-title":"Clin. Exp. Allergy."},{"key":"10.1016\/j.smim.2015.03.004_bib1820","doi-asserted-by":"crossref","first-page":"174ra26","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1825","doi-asserted-by":"crossref","first-page":"e24422","DOI":"10.1371\/journal.pone.0024422","article-title":"Impaired phagocytosis in localized aggressive periodontitis: rescue by resolvin E1","volume":"6","author":"Fredman","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1830","doi-asserted-by":"crossref","first-page":"C1141","DOI":"10.1152\/ajpcell.00351.2012","article-title":"Diversity of lipid mediators in human adipose tissue depots","volume":"304","author":"Claria","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.smim.2015.03.004_bib1835","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbalip.2012.07.011","article-title":"Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC\u2013MS\/MS","volume":"1821","author":"Giera","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.smim.2015.03.004_bib1840","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and hyper-responsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1845","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.2500\/ajra.2011.25.3726","article-title":"Cyclooxygenase 2 and lipoxin A(4) in nasal polyps in cystic fibrosis","volume":"25","author":"Rozsasi","year":"2011","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.smim.2015.03.004_bib1850","doi-asserted-by":"crossref","first-page":"e39244","DOI":"10.1371\/journal.pone.0039244","article-title":"Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis","volume":"7","author":"Vong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1855","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.200810-1601OC","article-title":"15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury","volume":"180","author":"El Kebir","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1860","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.0409271102","article-title":"Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis","volume":"102","author":"Arita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1865","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pupt.2011.04.001","article-title":"Resolvin D1 protects mice from LPS-induced acute lung injury","volume":"24","author":"Wang","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.smim.2015.03.004_bib1870","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1524-475X.2012.00853.x","article-title":"Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model","volume":"21","author":"Bohr","year":"2013","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.smim.2015.03.004_bib1875","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M410638200","article-title":"A role for the mouse 12\/15-lipoxygenase pathway in promoting epithelial wound healing and host defense","volume":"280","author":"Gronert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2015.03.004_bib1880","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1096\/fj.06-7918com","article-title":"Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing","volume":"21","author":"Biteman","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1885","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators","volume":"22","author":"Merched","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2015.03.004_bib1890","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent anti-inflammatory and pro-resolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1895","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.4049\/jimmunol.0900327","article-title":"12\/15-lipoxygenase counteracts inflammation and tissue damage in arthritis","volume":"183","author":"Kronke","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1900","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2353\/ajpath.2010.090678","article-title":"Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury","volume":"176","author":"Leedom","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2015.03.004_bib1905","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/annrheumdis-2011-200745","article-title":"The 12\/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis","volume":"71","author":"Kronke","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2015.03.004_bib1910","doi-asserted-by":"crossref","first-page":"e73085","DOI":"10.1371\/journal.pone.0073085","article-title":"Omega-3 polyunsaturated fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models","volume":"8","author":"Tomio","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2015.03.004_bib1915","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/emmm.201201891","article-title":"Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation","volume":"5","author":"Koltsida","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1920","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.4049\/jimmunol.1202969","article-title":"Inhaled carbon monoxide accelerates resolution of inflammation via unique pro-resolving mediator--heme oxygenase-1 circuits","volume":"190","author":"Chiang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1925","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/mi.2013.71","article-title":"Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology","volume":"7","author":"Shirey","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1930","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.1003473","article-title":"5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis","volume":"186","author":"Blaho","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1935","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI23949","article-title":"Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production","volume":"115","author":"Bafica","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2015.03.004_bib1940","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20021183","article-title":"Parasite-induced lipoxin A(4) is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection","volume":"196","author":"Aliberti","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1945","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2014.11.010","article-title":"Aspirin-triggered 15-epi-lipoxin A4 signals through FPR2\/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation","volume":"179","author":"Petri","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.smim.2015.03.004_bib1950","doi-asserted-by":"crossref","first-page":"18685","DOI":"10.1073\/pnas.1410938111","article-title":"Nonredundant protective properties of FPR2\/ALX in polymicrobial murine sepsis","volume":"111","author":"Gobbetti","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2015.03.004_bib1955","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.1103688","article-title":"Resolvin E1 and chemokine-like receptor 1 mediate bone preservation","volume":"190","author":"Gao","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1960","article-title":"The impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes","author":"Herrera","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.smim.2015.03.004_bib1965","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib1970","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.200410-1413OC","article-title":"Diminished lipoxin biosynthesis in severe asthma","volume":"172","author":"Levy","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1975","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1399-3003.2000.16a08.x","article-title":"Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics","volume":"16","author":"Sanak","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.smim.2015.03.004_bib1980","doi-asserted-by":"crossref","first-page":"174fs7","DOI":"10.1126\/scitranslmed.3005881","article-title":"A new horizon in asthma: inhibiting ILC function","volume":"5","author":"Peebles","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2015.03.004_bib1985","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.atherosclerosis.2012.04.016","article-title":"The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes","volume":"223","author":"Gutierrez","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.smim.2015.03.004_bib1990","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2015.03.004_bib1995","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.4049\/jimmunol.1201272","article-title":"Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat","volume":"189","author":"Cl\u00e0ria","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2015.03.004_bib2000","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s11306-012-0417-5","article-title":"Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations","volume":"8","author":"Zivkovic","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.smim.2015.03.004_bib2005","doi-asserted-by":"crossref","first-page":"C39","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.smim.2015.03.004_bib2010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nchembio.364","article-title":"Metabolic oxidation regulates embryonic stem cell differentiation","volume":"6","author":"Yanes","year":"2010","journal-title":"Nat. Chem. Biol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532315000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532315000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:32:39Z","timestamp":1566527559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532315000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":203,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1044532315000123"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2015.03.004","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}